Lyell Immunopharma Inc Capital Reinvestment Ratio
Lyell Immunopharma Inc capital reinvestment ratio. Lyell Immunopharma Inc (LYEL) has a Capital Reinvestment Ratio of 0.41x as of December 2019, meaning it reinvests 0% of its operating cash flow ($39.47 Million) in capital expenditures ($16.05 Million). Check Lyell Immunopharma Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Lyell Immunopharma Inc (2019–2019)
Capital reinvestment ratio of Lyell Immunopharma Inc from 2019 to 2019. This chart tracks Lyell Immunopharma Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Lyell Immunopharma Inc (LYEL) net asset momentum to track the company's year-over-year net asset growth rate.
Lyell Immunopharma Inc Capital Reinvestment Ratio by Year (2019–2019)
Lyell Immunopharma Inc capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see cash flow conversion of Lyell Immunopharma Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.41x | $39.47 Million | $16.05 Million | — |